- Home
- SLQT vs PCRX Comparison
SLQT vs PCRX Comparison
Compare SLQT & PCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLQT
- PCRX
- Stock Information
- Founded
- SLQT 1999
- PCRX 2006
- Country
- SLQT United States
- PCRX United States
- Employees
- SLQT N/A
- PCRX N/A
- Industry
- SLQT Specialty Insurers
- PCRX Biotechnology: Pharmaceutical Preparations
- Sector
- SLQT Finance
- PCRX Health Care
- Exchange
- SLQT Nasdaq
- PCRX Nasdaq
- Market Cap
- SLQT 343.7M
- PCRX 1.2B
- IPO Year
- SLQT 2020
- PCRX 2011
- Fundamental
- Price
- SLQT $2.08
- PCRX $26.86
- Analyst Decision
- SLQT Hold
- PCRX Buy
- Analyst Count
- SLQT 2
- PCRX 6
- Target Price
- SLQT $4.38
- PCRX $30.00
- AVG Volume (30 Days)
- SLQT 2.8M
- PCRX 592.7K
- Earning Date
- SLQT 11-03-2025
- PCRX 11-05-2025
- Dividend Yield
- SLQT N/A
- PCRX N/A
- EPS Growth
- SLQT N/A
- PCRX N/A
- EPS
- SLQT 0.01
- PCRX N/A
- Revenue
- SLQT $1,526,594,000.00
- PCRX $705,848,000.00
- Revenue This Year
- SLQT $13.85
- PCRX $7.36
- Revenue Next Year
- SLQT $13.64
- PCRX $10.07
- P/E Ratio
- SLQT $154.53
- PCRX N/A
- Revenue Growth
- SLQT 15.50
- PCRX 2.25
- 52 Week Low
- SLQT $1.62
- PCRX $13.04
- 52 Week High
- SLQT $6.86
- PCRX $27.64
- Technical
- Relative Strength Index (RSI)
- SLQT 47.83
- PCRX 61.04
- Support Level
- SLQT $1.91
- PCRX $25.63
- Resistance Level
- SLQT $2.18
- PCRX $27.11
- Average True Range (ATR)
- SLQT 0.12
- PCRX 0.96
- MACD
- SLQT -0.02
- PCRX -0.05
- Stochastic Oscillator
- SLQT 25.19
- PCRX 68.80
About SLQT SelectQuote Inc.
SelectQuote Inc is a Direct-to-consumer (DTC) distribution platform which facilitates consumers to shop for health, life and auto & home insurance policies online. The company generates its revenues by selling insurance products on behalf of the insurance carrier partners in the form of a commission. It has four reportable segments namely Senior, Healthcare Services, Life, and Auto & Home. It functions through three lines namely, SelectQuote Senior, SelectQuote Life, and SelectQuote Auto & Home.
About PCRX Pacira BioSciences Inc.
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.